Literature DB >> 26871999

Perceptions of the Cause, Impact and Management of Persistent Fatigue in Patients with Rheumatoid Arthritis Following Tumour Necrosing Factor Inhibition Therapy.

Patricia Minnock1, Anders Ringnér2, Barry Bresnihan1,3,4, Douglas Veale1,3,5,6, Oliver FitzGerald1,3,4,6, Gabrielle McKee7.   

Abstract

INTRODUCTION: Fatigue is a major symptom of rheumatoid arthritis (RA), the most common chronic inflammatory joint disease. The present study explored patients' experiences of RA fatigue to elucidate unique elements and management strategies.
METHODS: This single site study recruited tumour necrosis factor-α inhibitor (TNFi)-treated RA patients with a moderate/good response in disease activity and persistent moderate/greater fatigue on a five-point verbal rating scale. This qualitative descriptive design used semi-structured questions, individual interviews and content analysis of narrative data.
RESULTS: Ten patients were interviewed (six women), with age and disease duration ranges of 44-75 and 6-36 years, respectively. Perceptions of the RA fatigue experience generated four categories (experiencing a distinct, yet seldom discussed RA symptom; seeking an explanation for fatigue; being in an incapacitating state; and trying to manage) and eight subcategories. Fatigue was newly identified as a distinct part of the entity of RA. While patients proposed many plausible root causes, the only rational explanation for the nature of this fatigue was that it was integral to their RA. Singularly, fatigue contributed considerably to RA-imposed lifestyle restrictions. Patients had learnt to accommodate and self-manage fatigue in the absence of professional input. Novel management strategies proposed included patients talking about the nature of RA fatigue with others and the need for staff to alert patients to this distinct symptom of RA.
CONCLUSION: Fatigue, branded as a distinct symptom of RA, exerted an identifiable impact on patients. Fatigue is potentially amenable to modification; talking about fatigue was proposed as a novel management strategy.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Rheumatoid arthritis; fatigue; patient perspectives; qualitative content analysis

Mesh:

Substances:

Year:  2016        PMID: 26871999     DOI: 10.1002/msc.1136

Source DB:  PubMed          Journal:  Musculoskeletal Care        ISSN: 1478-2189


  4 in total

1.  Increased Incidence of Fatigue in Patients with Primary Immunodeficiency Disorders: Prevalence and Associations Within the US Immunodeficiency Network Registry.

Authors:  Joud Hajjar; Danielle Guffey; Charles G Minard; Jordan S Orange
Journal:  J Clin Immunol       Date:  2017-01-26       Impact factor: 8.317

Review 2.  Fatigue in Rheumatoid Arthritis.

Authors:  Patricia Katz
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

Review 3.  Predictors of fatigue in rheumatoid arthritis.

Authors:  Katie L Druce; Neil Basu
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

Review 4.  A Qualitative Metasynthesis of the Experience of Fatigue Across Five Chronic Conditions.

Authors:  Rosario B Jaime-Lara; Brittany C Koons; Lea Ann Matura; Nancy A Hodgson; Barbara Riegel
Journal:  J Pain Symptom Manage       Date:  2019-12-20       Impact factor: 3.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.